FDA Orange Book · active-ingredient family
Zavegepant hydrochloride
Zavegepant hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ZAVZPRET · NDA 216386
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
1
Exclusivity periods
Brand (NDA) products · spray, metered
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZAVZPRETRLD | PFIZER | NDA 216386 | — | Mar 09, 2023 |
Marketing exclusivity (1)
- NCENew chemical entity exclusivity (5 years)
Mar 09, 2028
in 1 yr 9 mo
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8481546 | Jun 26, 2034 | in 8 yr 2 mo | SubstanceProductU-3555 |
Zavegepant hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

